These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29680373)

  • 41. Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria.
    Shanks GD; Gordon DM; Klotz FW; Aleman GM; Oloo AJ; Sadie D; Scott TR
    Clin Infect Dis; 1998 Sep; 27(3):494-9. PubMed ID: 9770146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment].
    Forestier E; Labe A; Raffenot D; Lecomte C; Rogeaux O
    Med Mal Infect; 2011 Jan; 41(1):41-3. PubMed ID: 20800398
    [No Abstract]   [Full Text] [Related]  

  • 43. The safety of atovaquone/proguanil in long-term malaria prophylaxis of nonimmune adults.
    Petersen E
    J Travel Med; 2003 May; 10 Suppl 1():S13-5; discussion S21. PubMed ID: 12737755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children.
    Tahar R; Almelli T; Debue C; Foumane Ngane V; Djaman Allico J; Whegang Youdom S; Basco LK
    J Infect Dis; 2014 Dec; 210(12):1962-71. PubMed ID: 24943722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atovaquone and proguanil hydrochloride.
    Am J Health Syst Pharm; 2000 Dec; 57(23):2165-6. PubMed ID: 11127694
    [No Abstract]   [Full Text] [Related]  

  • 46. [symbol: see text] Atovaquone + proguanil for malaria prophylaxis.
    Drug Ther Bull; 2001 Oct; 39(10):73-5. PubMed ID: 11706518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atovaquone-proguanil treatment failure in a case of pediatric Plasmodium falciparum infection: Malabsorption and resistance.
    L'Huillier AG; Lau R; Bitnun A; Boggild AK
    Travel Med Infect Dis; 2020; 37():101829. PubMed ID: 32763494
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group.
    Kimura M; Koga M; Kikuchi T; Miura T; Maruyama H
    Parasitol Int; 2012 Sep; 61(3):466-9. PubMed ID: 22484597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Further observation of travellers taking twice-weekly atovaquone-proguanil prophylaxis in sub-Saharan Africa.
    Biber A; Harel R; Schwartz E
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30690466
    [No Abstract]   [Full Text] [Related]  

  • 50. Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases.
    Cordel H; Cailhol J; Matheron S; Bloch M; Godineau N; Consigny PH; Gros H; Campa P; Bourée P; Fain O; Ralaimazava P; Bouchaud O
    Malar J; 2013 Nov; 12():399. PubMed ID: 24200190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
    Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
    Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.
    Mavrogordato A; Lever AM
    J Infect; 2012 Sep; 65(3):269-74. PubMed ID: 22609735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A case of acute generalized exanthematous pustulosis caused by exposure to Atovaquone/proguanil.
    Arsuaga M; de Miguel R; Trigo E; Barreiro P; de la Calle F; Tarin EJ; Loli-Ausejo D; Diaz M
    J Travel Med; 2020 Sep; 27(6):. PubMed ID: 32163144
    [No Abstract]   [Full Text] [Related]  

  • 54. New options for the prevention and treatment of malaria: focus on the role of atovaquone and proguanil hydrochloride.
    Shanks GD
    J Travel Med; 1999 May; 6 Suppl 1():S1. PubMed ID: 23573544
    [No Abstract]   [Full Text] [Related]  

  • 55. Selection of Cytochrome
    Lin JT; Waltmann A; Moser KA; Park Z; Na YB; Aydemir O; Brazeau NF; Gosi P; Marsh PW; Muller MS; Spring M; Sok S; Bailey JA; Saunders DL; Lon C; Wojnarski M
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mefloquine has more adverse effects than other drugs for malaria prophylaxis.
    Eaton L
    BMJ; 2009 Oct; 339():b4167. PubMed ID: 19825970
    [No Abstract]   [Full Text] [Related]  

  • 57. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
    Blanchard A; Hine P
    Emergencias; 2023 Apr; 35(2):139-141. PubMed ID: 37038945
    [No Abstract]   [Full Text] [Related]  

  • 58. Antimalarial pharmacology and therapeutics of atovaquone.
    Nixon GL; Moss DM; Shone AE; Lalloo DG; Fisher N; O'Neill PM; Ward SA; Biagini GA
    J Antimicrob Chemother; 2013 May; 68(5):977-85. PubMed ID: 23292347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children.
    Mulenga M; Malunga F; Bennett S; Thuma PE; Shulman C; Fielding K; Alloueche A; Greenwood BM
    Trop Med Int Health; 2006 Nov; 11(11):1643-52. PubMed ID: 17054743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prophylactic use of antimalarials during pregnancy.
    Irvine MH; Einarson A; Bozzo P
    Can Fam Physician; 2011 Nov; 57(11):1279-81. PubMed ID: 22084457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.